Elevated body mass index as a risk factor for chronic kidney disease: current perspectives

References

• National Kidney Foundation K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification Am J Kidney Dis 2002 39 S1 S266 11904577
   PubMed Web of Science ®Google Scholar
• Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group. KDIGO 2012 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease Kidney Int Suppl 2013 3 1 150
   PubMed Web of Science ®Google Scholar
• Levin A Djurdjev O Beaulieu M Er L Variability and risk factors for kidney disease progression and death following attainment of stage 4 CKD in a referred cohort Am J Kidney Dis 2008 52 4 661 671 18805347
   PubMed Web of Science ®Google Scholar
• McCullough K Sharma P Ali T Measuring the population burden of chronic kidney disease: a systematic literature review of the estimated prevalence of impaired kidney function Nephrol Dial Transplant 2012 27 5 1812 1821 21965592
   PubMed Web of Science ®Google Scholar
• Turin TC Tonelli M Manns BJ Lifetime risk of ESRD J Am Soc Nephrol 2012 23 9 1569 1578 22904351
   PubMed Web of Science ®Google Scholar
• Boulware LE Jaar BG Tarver-Carr ME Screening for proteinuria in US adults: a cost-effectiveness analysis JAMA 2003 290 3101 3114 14679273
   PubMed Web of Science ®Google Scholar
• Levey AS Atkins R Coresh J Chronic kidney disease as a global public health problem: approaches andinitiatives – a position statement from Kidney Disease Improving Global Outcomes Kidney Int 2007 72 3 247 259 17568785
   PubMed Web of Science ®Google Scholar
• World Health Organization [homepage on the Internet] Obesity and overweight Geneva World Health Organization 2012 Available from: http://www.who.int/mediacentre/factsheets/fs311/en Accessed December 19, 2013
   Google Scholar
• Gotay CC Katzmarzyk PT Janssen I Dawson MY Aminoltejari K Bartley NL Updating the Canadian obesity maps: an epidemic in progress Can J Public Health 2012 104 1 e64 e68 23618109
   PubMed Web of Science ®Google Scholar
• Henegar JR Bigler SA Henegar LK Functional and structural changes in the kidney in the early stages of obesity J Am Soc Nephrol 2001 12 1211 1217 11373344
   PubMed Web of Science ®Google Scholar
• Kasiske BL Crosson JT Renal disease in patients with massive obesity Arch Intern Med 1986 146 1105 1109 3718096
   PubMed Web of Science ®Google Scholar
• de Jong PE Verhave JC Pinto-Sietsma SJ Hillege HL Obesity and target organ damage: the kidney Int J Obes Relat Metab Disord 2002 26 S21 S24 12457295
   PubMed Web of Science ®Google Scholar
• Chagnac A Weinstein T Korzets A Glomerular hemodynamics in severe obesity Am J Physiol Renal Physiol 2000 278 F817 F822 10807594
   PubMed Web of Science ®Google Scholar
• Rüster C Wolf G Adipokines promote chronic kidney disease Nephrol Dial Transplant 2013 28 Suppl 4 iv8 iv14 24179016
   PubMed Web of Science ®Google Scholar
• National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report Circulation 2002 106 3143 3421 12485966
   PubMed Web of Science ®Google Scholar
• Ford ES Li C Sattar N Metabolic syndrome and incident diabetes: current state of the evidence Diabetes Care 2008 31 1898 1904 18591398
   PubMed Web of Science ®Google Scholar
• Galassi A Reynolds K He J Metabolic syndrome and risk of cardiovascular disease: a meta-analysis Am J Med 2006 119 812 819 17000207
   PubMed Web of Science ®Google Scholar
• Chen J Muntner P Hamm LL The metabolic syndrome and chronic kidney disease in US adults Ann Intern Med 2004 140 3 167 174 14757614
   PubMed Web of Science ®Google Scholar
• Ninomiya T Kiyohara Y Kubo M Metabolic syndrome and CKD in a general Japanese population: the Hisayama Study Am J Kidney Dis 2006 48 3 383 391 16931211
   PubMed Web of Science ®Google Scholar
• Kern PA Ranganathan S Li C Wood L Ranganathan G Adipose tissue tumor necrosis factor and interleukin-6 expression in human obesity and insulin resistance Am J Physiol Endocrinol Metab 2001 280 5 E745 E751 11287357
   PubMed Web of Science ®Google Scholar
• Suganami T Nishida J Ogawa Y A paracrine loop between adipocytes and macrophages aggravates inflammatory changes: role of free fatty acids and tumor necrosis factor alpha Arterioscler Thromb Vasc Biol 2005 25 10 2062 2068 16123319
   PubMed Web of Science ®Google Scholar
• Manabe I Chronic inflammation links cardiovascular, metabolic and renal diseases Circ J 2011 75 12 2739 2748 22067929
   PubMed Web of Science ®Google Scholar
• Thomas G Sehgal AR Kashyap SR Srinivas TR Kirwan JP Navaneethan SD Metabolic syndrome and kidney disease: a systematic review and meta-analysis Clin J Am Soc Nephrol 2011 6 10 2364 2373 21852664
   PubMed Web of Science ®Google Scholar
• Kadowaki T Yamauchi T Kubota N Hara K Ueki K Tobe K Adiponectin and adiponectin receptors in insulin resistance, diabetes, and the metabolic syndrome J Clin Invest 2006 116 7 1784 1792 16823476
   PubMed Web of Science ®Google Scholar
• Kacso IM Bondor CI Kacso G Plasma adiponectin is related to the progression of kidney disease in type 2 diabetes patients Scand J Clin Lab Invest 2012 72 4 333 339 22486808
   PubMed Web of Science ®Google Scholar
• Zoccali C Mallamaci F Tripepi G Adiponectin, metabolic risk factors, and cardiovascular events among patients with end-stage renal disease J Am Soc Nephrol 2002 13 1 134 141 11752030
   PubMed Web of Science ®Google Scholar
• Sharma K Ramachandrarao S Qiu G Adiponectin regulates albuminuria and podocyte function in mice J Clin Invest 2008 118 5 1645 1656 18431508
   PubMed Web of Science ®Google Scholar
• Yilmaz MI Saglam M Carrero JJ Serum visfatin concentration and endothelial dysfunction in chronic kidney disease Nephrol Dial Transplant 2008 23 3 959 965 17984105
   PubMed Web of Science ®Google Scholar
• Koshimura J Fujita H Narita T Urinary adiponectin excretion is increased in patients with overt diabetic nephropathy Biochem Biophys Res Commun 1994 316 165 169 15003525
   PubMed Web of Science ®Google Scholar
• Considine RV Sinha MK Heiman ML Serum immunoreactive leptin concentrations in normal-weight and obese humans N Engl J Med 1996 334 5 292 295 8532024
   PubMed Web of Science ®Google Scholar
• Adamczak M Wiecek A The adipose tissue as an endocrine organ Semin Nephrol 2013 33 1 2 13 23374889
   PubMed Web of Science ®Google Scholar
• Shankar A Syamala S Xiao J Muntner P Relationship between plasma leptin level and chronic kidney disease Int J Nephrol 2012 2012 269532 22666590
   PubMedGoogle Scholar
• Nordfors L Lönnqvist F Heimbürger O Danielsson A Schalling M Stenvinkel P Low leptin gene expression and hyperleptinemia in chronic renal failure Kidney Int 1998 54 4 1267 1275 9767543
   PubMed Web of Science ®Google Scholar
• Nasrallah MP Ziyadeh FN Overview of the physiology and pathophysiology of leptin with special emphasis on its role in the kidney Semin Nephrol 2013 33 1 54 65 23374894
   PubMed Web of Science ®Google Scholar
• Tang J Yan H Zhuang S Inflammation and oxidative stress in obesity-related glomerulopathy Int J Nephrol 2012 2012 608397 22567283
   PubMedGoogle Scholar
• Han DC Isono M Chen S Leptin stimulates type I collagen production in db/db mesangial cells: glucose uptakeand TGF-beta type II receptor expression Kidney Int 2001 59 4 1315 1323 11260392
   PubMed Web of Science ®Google Scholar
• Steppan CM Bailey ST Bhat S The hormone resistin links obesity to diabetes Nature 2001 409 6818 307 312 11201732
   PubMed Web of Science ®Google Scholar
• Stępień M Stępień A Wlazeł RN Obesity indices and adipokines in non-diabetic obese patients with early stages of chronic kidney disease Med Sci Monit 2013 19 1063 1072 24280776
   PubMed Web of Science ®Google Scholar
• Axelsson J Bergsten A Qureshi AR Elevated resistin levels in chronic kidney disease are associated with decreased glomerular filtration rate and inflammation, but not with insulin resistance Kidney Int 2006 69 3 596 604 16395259
   PubMed Web of Science ®Google Scholar
• Kielstein JT Becker B Graf S Brabant G Haller H Fliser D Increased resistin blood levels are not associated with insulin resistance in patients with renal disease Am J Kidney Dis 2003 42 1 62 66 12830457
   PubMed Web of Science ®Google Scholar
• Axelsson J Witasp A Carrero JJ Circulating levels of visfatin/pre-B-cell colony-enhancing factor 1 in relation to genotype, GFR, body composition, and survival in patients with CKD Am J Kidney Dis 2007 49 2 237 244 17261426
   PubMed Web of Science ®Google Scholar
• Carrero JJ Witasp A Stenvinkel P Visfatin is increased in chronic kidney disease patients with poor appetite and correlates negatively with fasting serum amino acids and triglyceride levels Nephrol Dial Transplant 2010 25 3 901 906 19948877
   PubMed Web of Science ®Google Scholar
• Cassis LA Police SB Yiannikouris F Thatcher SE Local adipose tissue renin-angiotensin system Curr Hypertens Rep 2008 10 2 93 98 18474174
   PubMed Web of Science ®Google Scholar
• Boustany CM Bharadwaj K Daugherty A Brown DR Randall DC Cassis LA Activation of the systemic and adipose renin-angiotensin system in rats with diet-induced obesity and hypertension Am J Physiol Regul Integr Comp Physiol 2004 287 4 R943 R949 15191907
   PubMed Web of Science ®Google Scholar
• Iseki K Ikemiya Y Kinjo K Body mass index and the risk of development of end-stage renal disease in a screened cohort Kidney Int 2004 65 1870 1876 15086929
   PubMed Web of Science ®Google Scholar
• Hallan S de Mutsert R Carlsen S Obesity, smoking, and physical inactivity as risk factors for CKD: are men more vulnerable? Am J Kidney Dis 2006 47 396 405 16490617
   PubMed Web of Science ®Google Scholar
• Gelber RP Kurth T Kausz AT Association between body mass index and CKD in apparently healthy men Am J Kidney Dis 2005 46 871 880 16253727
   PubMed Web of Science ®Google Scholar
• Hsu CY McCulloch CE Iribarren C Body mass index and risk for end-stage renal disease Ann Intern Med 2006 144 21 28 16389251
   PubMed Web of Science ®Google Scholar
• Kramer H Luke A Bidani A Obesity andprevalent and incident CKD: the hypertension detection and follow-up program Am J Kidney Dis 2005 46 587 594 16183412
   PubMed Web of Science ®Google Scholar
• Stengel B Tarrer-Carr ME Powe NR Life style factors, obesity and the risk of chronic kidney disease Epidemiology 2003 14 479 487 12843775
   PubMed Web of Science ®Google Scholar
• Wang Y Chen X Song Y Caballero B Cheskin LJ Association between obesity and kidney disease: a systematic review and meta-analysis Kidney Int 2008 73 1 19 33 17928825
   PubMed Web of Science ®Google Scholar
• Elsayed EF Sarnak MJ Tighiouart H Waist-to-hip ratio, body mass index, and subsequent kidney disease and death Am J Kidney Dis 2008 52 1 29 38 18511168
   PubMed Web of Science ®Google Scholar
• Noori N Hosseinpanah F Nasiri AA Azizi F Comparison of overall obesity and abdominal adiposity in predicting chronic kidney disease incidence among adults J Ren Nutr 2009 19 3 228 237 19261489
   PubMed Web of Science ®Google Scholar
• Fox CS Larson MG Leip EP Culleton B Wilson PW Levy D Predictors of new-onset kidney disease in a community-based population JAMA 2004 291 7 844 850 14970063
   PubMed Web of Science ®Google Scholar
• Garland JS Holden RM Hopman WM Gill SS Nolan RL Morton AR Body mass index, coronary artery calcification, and kidney function decline in stage 3 to 5 chronic kidney disease patients J Ren Nutr 2013 23 1 4 11 22542819
   PubMed Web of Science ®Google Scholar
• Othman M Kawar B El Nahas AM Influence of obesity on progression of non-diabetic chronic kidney disease: a retrospective cohort study Nephron Clin Pract 2009 113 1 c16 c23 19590231
   PubMedGoogle Scholar
• Kovesdy CP Anderson JE Kalantar-Zadeh K Paradoxical association between body mass index and mortality in men with CKD not yet on dialysis Am J Kidney Dis 2007 49 5 581 591 17472839
   PubMed Web of Science ®Google Scholar
• Beddhu S The body mass index paradox and an obesity, inflammation, and atherosclerosis syndrome in chronic kidney disease Semin Dial 2004 17 229 232 15144550
   PubMed Web of Science ®Google Scholar